A nitric oxide processing defect of red blood cells created by hypoxia: Deficiency of S-nitrosohemoglobin in pulmonary hypertension
T. McMahon(Durham VA Health Care System), Jonathan S. Stamler(Discovery Institute), Victor F. Tapson(Cedars-Sinai Medical Center), Gregory S. Ahearn(Howard Hughes Medical Institute), Raphael Nudelman(Teva Pharmaceuticals (Israel)), David J. Singel(Howard Hughes Medical Institute), Benjamin P. Luchsinger(Howard Hughes Medical Institute), Claude A. Piantadosi(Duke University), Martín P Moya(Howard Hughes Medical Institute), Abigail Krichman(Howard Hughes Medical Institute), Robert M. Califf(Duke University), Thomas M. Bashore(Howard Hughes Medical Institute), Yuh-Chin T. Huang(Howard Hughes Medical Institute), Andrew J. Gow(Howard Hughes Medical Institute)
Cited by 132
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
|European Heart Journal|2011|614
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603
Myonecrosis After Revascularization Procedures
|Journal of the American College of Cardiology|1998|553